These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 33160014)
1. Organoid model: A new hope for pancreatic cancer treatment? Chen H; Zhuo Q; Ye Z; Xu X; Ji S Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188466. PubMed ID: 33160014 [TBL] [Abstract][Full Text] [Related]
2. Personalizing pancreatic cancer organoids with hPSCs. Zhang HC; Kuo CJ Nat Med; 2015 Nov; 21(11):1249-51. PubMed ID: 26540385 [No Abstract] [Full Text] [Related]
3. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Tiriac H; Belleau P; Engle DD; Plenker D; Deschênes A; Somerville TDD; Froeling FEM; Burkhart RA; Denroche RE; Jang GH; Miyabayashi K; Young CM; Patel H; Ma M; LaComb JF; Palmaira RLD; Javed AA; Huynh JC; Johnson M; Arora K; Robine N; Shah M; Sanghvi R; Goetz AB; Lowder CY; Martello L; Driehuis E; LeComte N; Askan G; Iacobuzio-Donahue CA; Clevers H; Wood LD; Hruban RH; Thompson E; Aguirre AJ; Wolpin BM; Sasson A; Kim J; Wu M; Bucobo JC; Allen P; Sejpal DV; Nealon W; Sullivan JD; Winter JM; Gimotty PA; Grem JL; DiMaio DJ; Buscaglia JM; Grandgenett PM; Brody JR; Hollingsworth MA; O'Kane GM; Notta F; Kim E; Crawford JM; Devoe C; Ocean A; Wolfgang CL; Yu KH; Li E; Vakoc CR; Hubert B; Fischer SE; Wilson JM; Moffitt R; Knox J; Krasnitz A; Gallinger S; Tuveson DA Cancer Discov; 2018 Sep; 8(9):1112-1129. PubMed ID: 29853643 [TBL] [Abstract][Full Text] [Related]
4. Organoid models for translational pancreatic cancer research. Tiriac H; Plenker D; Baker LA; Tuveson DA Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513 [TBL] [Abstract][Full Text] [Related]
5. Organoid technology in cancer precision medicine. Xia X; Li F; He J; Aji R; Gao D Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736 [TBL] [Abstract][Full Text] [Related]
6. Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment. Saito Y J Gastroenterol Hepatol; 2019 Nov; 34(11):1906-1910. PubMed ID: 31264257 [TBL] [Abstract][Full Text] [Related]
7. Organoid technology and applications in cancer research. Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074 [TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer. Zhang Y; Houchen CW; Li M Clin Cancer Res; 2022 Aug; 28(15):3176-3178. PubMed ID: 35617521 [TBL] [Abstract][Full Text] [Related]
10. Organoid models of human and mouse ductal pancreatic cancer. Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080 [TBL] [Abstract][Full Text] [Related]
11. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134 [TBL] [Abstract][Full Text] [Related]
12. Patient-derived cancer organoids for drug screening: Basic technology and clinical application. Ren X; Chen W; Yang Q; Li X; Xu L J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719 [TBL] [Abstract][Full Text] [Related]
13. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Tiriac H; Bucobo JC; Tzimas D; Grewel S; Lacomb JF; Rowehl LM; Nagula S; Wu M; Kim J; Sasson A; Vignesh S; Martello L; Munoz-Sagastibelza M; Somma J; Tuveson DA; Li E; Buscaglia JM Gastrointest Endosc; 2018 Jun; 87(6):1474-1480. PubMed ID: 29325707 [TBL] [Abstract][Full Text] [Related]
14. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832 [TBL] [Abstract][Full Text] [Related]
15. The application of pancreatic cancer organoids for novel drug discovery. Melzer MK; Resheq Y; Navaee F; Kleger A Expert Opin Drug Discov; 2023 Apr; 18(4):429-444. PubMed ID: 36945198 [TBL] [Abstract][Full Text] [Related]
16. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study. Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038 [TBL] [Abstract][Full Text] [Related]
17. [Application of Organoids in Lung Cancer Precision Medicine]. Jia Z; Liang N; Li S Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):615-620. PubMed ID: 32702796 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. Tanaka C; Furihata K; Naganuma S; Ogasawara M; Yoshioka R; Taniguchi H; Furihata M; Taniuchi K Hum Cell; 2022 Mar; 35(2):735-744. PubMed ID: 35150409 [TBL] [Abstract][Full Text] [Related]
19. [Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer]. Wang HW; Ma XQ; Gao S; Hao JH Zhonghua Wai Ke Za Zhi; 2024 Jul; 62(7):710-713. PubMed ID: 38808439 [TBL] [Abstract][Full Text] [Related]